Catalyst

Slingshot members are tracking this event:

Phase 3 Study of SHP465 in Adults with ADHD Due End of Q1 of 2016

Source Link:
http://seekingalpha.com/article/3889296-shire-plcs-shpg-ceo-flemming-ornskov-q4-2015-results-earnings-call-transcript?part=single

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
SHPG
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Shire is expected to release data from a Phase 3 study of SHP465 on the treatment of adult patients with ADHD at the end of the first quarter of 2016.  
http://seekingalpha....
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jun 29, 2016
Occurred Source:
https://www.shire.com/newsroom/2016/june/a5qnn5
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3 Study, Shp465, Adhd
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.